arbutamine has been researched along with Myocardial Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergmann, K; Glatz, S; Höher, M; Kotzerke, J; Reske, SN | 1 |
| De Landsheere, CM; Degueldre, C; Kulbertus, HE; Lancellotti, P; Melon, PG; Pierard, LA | 1 |
2 other study(ies) available for arbutamine and Myocardial Infarction
| Article | Year |
|---|---|
[Whole body distribution of Tc-99m-sestamibi after pharmacological stress with arbutamine and dipyridamole compared with resting conditions].
Topics: Adrenergic beta-Agonists; Adult; Aged; Blood Pressure; Catecholamines; Coronary Disease; Dipyridamole; Exercise Test; Female; Heart; Heart Rate; Humans; Lung; Male; Middle Aged; Myocardial Infarction; Rest; Technetium Tc 99m Sestamibi; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 1997 |
Identification of viable myocardium early after acute myocardial infarction using closed-loop arbutamine echocardiography: comparison with positron emission tomography.
Topics: Adrenergic beta-Agonists; Catecholamines; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |